Recursion Pharmaceuticals, Inc. earnings per share and revenue

RXRX earnings per share for the last quarter are -0.34 USD whereas the estimation was -0.33 USD which accounts for -2.15% surprise. Company revenue for the same period amounts to 26.08 M USD despite the estimated figure of 18.72 M USD. Estimated earnings per share for the next quarter are -0.42 USD, and revenue is expected to reach 12.19 M USD. Also watch annual changes over time to get a bigger picture of RXRX earnings per share and revenue dynamics.